Corcept Therapeutics Inc CORT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/11/21 EDT
21.53UNCH (UNCH)
Volume
9,506
Close
21.53quote price arrow up+0.01 (+0.05%)
Volume
429,883
52 week range
12.20 - 31.18

...

Loading . . .
  • Open21.66
  • Day High21.66
  • Day Low21.41
  • Prev Close21.52
  • 52 Week High31.18
  • 52 Week High Date02/09/21
  • 52 Week Low12.20
  • 52 Week Low Date08/27/20

Key Stats

  • Market Cap2.511B
  • Shares Out116.63M
  • 10 Day Average Volume0.48M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change-17.7

KEY STATS

  • Open21.66
  • Day High21.66
  • Day Low21.41
  • Prev Close21.52
  • 52 Week High31.18
  • 52 Week High Date02/09/21
  • 52 Week Low12.20
  • 52 Week Low Date08/27/20
  • Market Cap2.511B
  • Shares Out116.63M
  • 10 Day Average Volume0.48M
  • Dividend-
  • Dividend Yield-
  • Beta0.71
  • YTD % Change-17.7

RATIOS/PROFITABILITY

  • EPS (TTM)0.79
  • P/E (TTM)27.27
  • Fwd P/E (NTM)29.90
  • EBITDA (MRQ)110.67M
  • ROE (MRQ)21.60%
  • Revenue (MRQ)340.06M
  • Gross Margin (MRQ)98.54%
  • Net Margin (MRQ)29.23%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/02/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Corcept Therapeutics Inc

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive antagonist at the glucocorticoid receptor (GR). As of December 31, 2016, it had discovered three structurally distinct series of selective cortisol...
James Wilson
Non-Executive Chairman
Joseph Belanoff M.D.
President
Atabak Mokari
Chief Financial Officer
Joseph Lyon
Chief Accounting Officer
Address
149 Commonwealth Dr
Menlo Park, CA
94025-1133
United States

Top Peers

SYMBOLLASTCHG%CHG
PCRX
Pacira Biosciences Inc
60.52+1.34+2.26%
IRWD
Ironwood Pharmaceuticals Inc
11.73-0.04-0.34%
HSKA
Heska Corp
206.22+0.17+0.08%
INVA
Innoviva Inc
12.60+0.18+1.45%
AMRN
Amarin Corporation PLC
4.95+0.07+1.43%